NCT05271422CompletedNot Applicable
A Single Center, Single-blind, Exploratory Study to Evaluate the Efficacy and Safety of the Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for LASEK Surgery
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Nu Eyne Co., Ltd.
- Enrollment
- 24
- Locations
- 1
- Primary Endpoint
- Changes in Tear break-up time (T-BUT)
Study Overview
Brief Summary
This study aims to evaluate the efficacy and safety of applying pulse electrical stimulation around eye in dry eye disease patients who are scheduled for LASEK surgery.
Detailed Description
Duration of study period (per participant): Screening period (0-14 days), Intervention period (12 weeks), F/U period (2 weeks) Patient needs to visit site at least 9 times (Screening, baseline, V1, V2, V3, Tele-visit, V4, V5, F/U Tele-visit). Baseline visit will be done on the day of surgery. Visit 1, 2, 3, Tele-visit, 4, 5, F/U Tele-visit is 1 day, 3 days, 1 weeks, 2 weeks, 4 weeks, 12 weeks and 16weeks after baseline visit.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 19 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Participants must be 19 to 60 years of age, at the time of screening
- •Those who are scheduled to get LASEK surgery
- •According to the guidelines for diagnosing dry eye syndrome of Korean Corneal Disease Study Group, those who fall under Grade II or higher
- •Those with an OSDI score of 13 or higher
- •A person who has no pregnancy plan during the clinical trial period and has agreed to an effective contraceptive plan for Women of child bearing potential (WOCBP) by a doctor
- •A person who voluntarily agreed to participate in this clinical trial
Exclusion Criteria
- •Patients who meet any of the exclusion criteria are excluded from this clinical trial.
- •A person with an uncontrollable systemic chronic disease (diabetes mellitus)
- •Those who are allergic to drugs such as Fluorescein Solution or ophthalmic anesthetics
- •In a case where there is a history of receiving ophthalmic surgery known to affect the tear layer within the last 6 months (e.g., Cataract, Pterygium surgery)
- •A person who takes systemic drugs (e.g., tetracycline derivatives, antihistamine, isotretinoin)
- •A person who has eyelid diseases or structural abnormalities
- •A person with acute eye infection or inflammation of the eyeball not related to Meibomian gland dysfunction
- •A person with abnormalities in the eyelids or eyelashes
- •A person with an eye condition or ophthalmic disease that is considered unsuitable for surgery (e.g., detachment of the retina, cataract)
- •Pregnant or lactating women
- •Those who can't understand or read the consent form of this clinical trial (e.g., illiterate or foreigners)
- •Any other cases that PI considers hard to participate in this clinical trial (e.g., heart-related problems, seizure, epilepsy. Patients transplanted metal or electronic device in head & neck. Patient suffering from unknown pain. Patients who are warned not to use our clinical trial device or is prohibited from using it (e.g., pacemaker user).)
Arms & Interventions
Experimental Group
Experimental
Dry eye disease patients (n=12)
Intervention: Real Pulse Electrical Stimulation (NuEyne 01) (Device)
Control Group
Sham Comparator
Dry eye disease patients (n=12)
Intervention: Sham Pulse Electrical Stimulation (Device)
Outcomes
Primary Outcomes
Changes in Tear break-up time (T-BUT)
Time Frame: Time Frame: baseline, 1, 4, 12 weeks
Check the changes in Tear break-up time (T-BUT)
Changes in Ocular Surface Disease Index (OSDI) score
Time Frame: baseline, 1, 4, 12 weeks
Check the changes in Ocular Surface Disease Index (OSDI) score
Secondary Outcomes
- Changes in 5-Item Dry Eye Questionnaire (DEQ-5 score)(baseline, 1, 4, 12 weeks)
- Changes in Patient Evaluation of Eye Dryness (SPEED) II questionnaire score(baseline, 1, 4, 12 weeks)
- Changes in LipiView Eye Lipid Layer Thickness(baseline, 4, 12 weeks)
- Changes in Matrix Metalloproteinase-9 (MMP-9) level(baseline, 4, 12 weeks)
- Changes in Tear Volume(baseline, 1, 4, 12 weeks)
- Changes in Visual Analogue Scale (VAS) score(baseline, 1 day, 3 days, 7 days)
- Changes in Staining Score(baseline, 1, 4, 12 weeks)
- Changes in Tear Osmolarity(baseline, 4, 12 weeks)
- Changes in the length of the aesthesiometer's filament in centimeters(baseline, 1, 4, 12 weeks)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Study of Application of Pulse Electrical Stimulation Around Eye in Glaucoma PatientsGlaucomaNCT05159414Nu Eyne Co., Ltd.18
Recruiting
Not Applicable
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) SurgeryDry Eye DiseaseNCT06120348Nu Eyne Co., Ltd.178
Recruiting
Not Applicable
Study of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-related Macular DegenerationEarly to Moderate Dry Age-Related Macular DegenerationNCT05259371Nu Eyne Co., Ltd.25
Not yet recruiting
Not Applicable
Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell CarcinomaEsophageal CancerNCT06756841Energenx Medical LTD.10
Not yet recruiting
Not Applicable
A study for clinical effect of electrical stimulatiolocomotive syndromeJPRN-UMIN000015693Saitama Medical University department of orthopaedic surgery200